Solid Team:Management
Our management team has the breadth of experience and passion to bring meaningful therapies to patients with Duchenne muscular dystrophy (DMD).

Ilan Ganot
Co-Founder, President and CEO

Joel Schneider, Ph.D.
Chief Operating Officer

Carl Morris, Ph.D.
Chief Scientific Officer

Erin Powers Brennan
Chief Legal Officer & Secretary

Stephen DiPalma
Interim Chief Financial Officer

Roxana Donisa Dreghici, M.D.
Senior Vice President, Head of Clinical Development